WHO and TCM perspective on evidence and regulation

被引：0
|
作者：
Xue, CC [1 ]
机构：
[1] RMIT Univ, Div Chinese Med, Melbourne, Vic, Australia
来源：
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2004年 / 31卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：A220 / A221
页数：2
相关论文
共 50 条
  • [1] A process perspective on regulation: Who bears the dispersed costs of regulation?
    Thomas, Diana W.
    REVIEW OF AUSTRIAN ECONOMICS, 2018, 31 (04): : 395 - 402
  • [2] WHO GUIDE TO INCLUDE SECTION ON TCM
    不详
    MEDICAL ACUPUNCTURE, 2020, 32 (01) : 5 - 5
  • [3] The Mammary Carcinoma from the Perspective of the TCM
    Schmit, Kerstin
    SCHWEIZERISCHE ZEITSCHRIFT FUER GANZHEITSMEDIZIN, 2009, 21 (06): : 290 - 293
  • [4] WHO wants to include TCM in the ICD Compendium
    不详
    DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2019, 62 (01): : 71 - 71
  • [5] On the Assessment Standardization for TCM Clinical Evidence
    王莹莹
    杨金生
    王友京
    Journal of Traditional Chinese Medicine, 2008, (03) : 233 - 234
  • [6] Who accepts nudges? nudge acceptability from a self-regulation perspective
    van Gestel, Laurens C.
    Adriaanse, Marieke A.
    de Ridder, Denise T. D.
    PLOS ONE, 2021, 16 (12):
  • [7] Pharmacological examination of TCM should be evidence based
    Hawkes, David
    Benhamu, Joanne
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (03) : 111 - 112
  • [8] Dysmenorrhea and Endometriosis from the Perspective of TCM and holistic Therapy
    Giese, C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (06) : 752 - 752
  • [9] The WHO-INTEGRATE evidence to decision framework version 1.0: integrating WHO norms and values and a complexity perspective
    Rehfuess, Eva A.
    Stratil, Jan M.
    Scheel, Inger B.
    Portela, Anayda
    Norris, Susan L.
    Baltussen, Rob
    BMJ GLOBAL HEALTH, 2019, 4
  • [10] TCM Differentiation and Acupuncture Treatment for Regulation of the Subhealthy State
    宫艳华
    孙巧云
    JournalofTraditionalChineseMedicine, 2007, (01) : 22 - 25
12345